Aziz Mottiwala, Chief Commercial Officer at Tarsus Pharmaceuticals, Inc. (TARS), sold 9,532 shares at $30.60 ($292K) on 2024-03-18, disclosed to the SEC on 2024-03-19.
Open-market sale of $292k TARS by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.60 | 4,766 | $146K | 50.0% |
| 2 | $30.60 | 4,766 | $146K | 50.0% |
| Total | $30.60 avg | 9,532 | $292K | 100% |
| Filing → |
| TARS | SELL | 2025-03-20 | $1.0M | — | Filing → |
| TARS | SELL | 2023-07-21 | $48K | — | Filing → |
| TARS | SELL | 2023-06-12 | $2K | — | Filing → |